Using fluorescence-activated cell sorting followed by fluorescence in situ hybridization to study lineage relationships: The 8;21 translocation is present in neutrophils but not monocytes in a patient with severe congenital neutropenia and a granulocyte colony-stimulating factor-responsive clonal abnormality

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 91, Issue 438, 2002, Pages 120-123

  White, C ^a   Chen, Z ^a   Raetz, E ^a   Pulsipher, M ^a   Spangrude, G J ^a   Slayton, W B ^a  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Acute myelogenous leukemia; AML 1 ETO; Fluorescence in situ hybridization; Granulocyte colony stimulating factor; Severe congenital neutropenia

Indexed keywords

CYCLOSPORIN; LEUKOCYTE ELASTASE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; BLAST CELL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CASE REPORT; CELL LINEAGE; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CONFERENCE PAPER; FEMALE; FEVER; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; KOSTMANN SYNDROME; LEUKEMOGENESIS; MONOCYTE; MYELODYSPLASIA; NEUTROPENIA; NEUTROPHIL; PRESCHOOL CHILD; PRIORITY JOURNAL;

BONE MARROW TRANSPLANTATION; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 21; COMBINED MODALITY THERAPY; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MONOCYTES; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; NEUTROPHILS; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 0036429931     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Zeidler C, Boxer L, Dale DC, Freedman MH, Kinsey S, Welte K. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 2000; 109: 490-5
2. Dale DC. Hematopoietic growth factors for the treatment of severe chronic neutropenia. Stem Cells 1995; 13: 94-100
3. Kostmann R. Infantile genetic agranulocytosis. Acta Paediatr Scand 1956; 45: 309-10
4. Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96: 2317-22
5. Rosen RB, Kang SJ. ConGenital agranulocytosis terminating in acure myelomonocytic leukemia. J Pediatr 1979; 94: 406-8
6. Gilman PA, Jackson DP, Guild HG. Congenital agranulocytosis: Prolonged survival and terminal acure leukemia. Blood 1970; 36: 576-85
7. Freedman MH, Bonilla MA, Fier C, Bolyard AA, Scarlata D, Boxer LA, et al. Myelodysplasia syndrome and acure myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000; 96: 429-36
8. Slayton W, Spangrude G, Chen Z, Greene W, Virshup D. Lineage-specific trisomy-21 in a neonate with resolving transient myeloproliferative syndrome. J Pediatr Hematol Oncol 2002; in press
9. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11
10. Dong F, Dale DC, Bonilla MA, Freedman M, Fasth A, Neijens HJ, et al. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 1997; 11: 120-5
11. Hunter MG, Avalos BR. Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acure myelogenous leukemia confer resistance to apoptosis and enhance cell survival. Blood 2000; 95: 2132-7
12. Tschan CA, Pilz C, Zeidler C, Welte K, Germeshausen M. Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia. Blood 2001; 97: 1882-4
13. Hermans MH, Antonissen C, Ward AC, Mayen AE. Ploemacher RE, Touw IP. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med 1999; 189: 683-92
14. Hermans MH, Ward AC, Antonissen C, Karis A, Lowenberg B, Touw IP. Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. Blood 1998; 92: 32-9
15. McLemore ML, Poursine-Laurent J, Link DC. Increased granulocyte colony-stimulating factor responsiveness bur normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. J Clin Invest 1998; 102: 483-92
16. Jeha S, Chan KW, Aprikyan AG, Hoots WK, Culbert S, Zietz H, et al. Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia. Blood 2000; 96: 3647-9
17. Estey E, Trujillo JM, Cork A, O'Brien S, Beran M, Kantarjian H, et al. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes. Hematol Pathol 1992; 6: 43-8
18. Kojima K, Omoto E, Hara M, Sasaki K, Katayama Y, Nawa Y, et al. Myelodysplastic syndrome with translocation (8;21): A distinct myelodysplastic syndrome entity or M2-acute myeloid leukemia with extensive myeloid maturation? Ann Hematol 1998; 76: 279-82
19. Taj AS, Ross FM, Vickers M, Choudhury DN, Harvey JF, Barber JC, et al. t(8;21) myelodysplasia, an early presentation of M2 AML. Br J Haematol 1995; 89: 890-2
20. Xue Y, Yu F, Zhou Z, Guo Y, Xie X, Lin B. Translocation (8;21) in oligoblastic leukemia: Is this a true myelodysplastic syndrome? Leuk Res 1994; 18: 761-5
21. van Lom K, Hagemeijer A, Vandekerckhove F, de Greef GE, Sacchi N, Lowenberg B. Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): Only myeloid cells are part of the malignant clone. Leukemia 1997; 11: 202-5
22. Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acure myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 2000; 97: 7521-6